RSV vaccine manufacturers vie for market share in second year of vaccinations

Pfizer, GSK and Moderna’s competition to supply new respiratory syncytial virus (RSV) vaccines is on Wall Street’s watch list as the companies will report their earnings later this week.

Share This Post:

POPULAR POSTS
FOLLOW US
Like Us On Facebook
Follow Us On Twitter
Subscribe To Our Channel
TikTok
LIVE STREAM